1,086
Views
4
CrossRef citations to date
0
Altmetric
Theme: Endocrine Oncology - Editorial

Unravelling the best combination of therapies to treat anaplastic thyroid cancer

&
Pages 235-237 | Received 12 Jan 2016, Accepted 05 Apr 2016, Published online: 06 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Diana P. Sousa, Marta Pojo, Ana T. Pinto, Valeriano Leite, Ana Teresa Serra & Branca M. Cavaco. (2020) Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines. Nutrition and Cancer 72:2, pages 352-363.
Read now

Articles from other publishers (3)

Youwen Wang, Nailing Tang, Ting Zhao, Feng Gao, Xiaotong Teng, Longwu Xu, Chunzhen Zhao, Wenjing Li, Wei Tan & Baolong Zhou. (2023) Bacterial Structure‐Inspired Synthesis of Tumor‐Microenvironment‐Activated Artificial Enzyme toward Photothermal Enhanced Chemodynamic Cancer Therapy. ChemistrySelect 8:41.
Crossref
Shu-Fu Lin, Jen-Der Lin, Chuen Hsueh, Ting-Chao Chou & Richard J. Wong. (2017) Effects of roniciclib in preclinical models of anaplastic thyroid cancer. Oncotarget 8:40, pages 67990-68000.
Crossref
Karen Zwaenepoel, Julie Jacobs, Astrid De Meulenaere, Karen Silence, Evelien Smits, Vasiliki Siozopoulou, Esther Hauben, Christian Rolfo, Sylvie Rottey & Patrick Pauwels. (2017) CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy. Histopathology 71:3, pages 357-365.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.